HEPA

Hepion Pharmaceuticals (HEPA)

About Hepion Pharmaceuticals (HEPA)

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.

Details

Daily high

$0.30

Daily low

$0.26

Price at open

$0.28

52 Week High

$79.50

52 Week Low

$0.25

Market cap

3.1M

Dividend yield

0.00%

Volume

1.2M

Avg. volume

10.4M

P/E ratio

.00

Hepion Pharmaceuticals News